# An Extension of CTN 31GB0607 to Evaluate Long Term Safety of NASHA Treatment in the Breast

> **NCT01609400** · — · COMPLETED · sponsor: **Galderma R&D** · enrollment: 11 (actual)

## Conditions studied

- Breast Enhancement

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01609400
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2022-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01609400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01609400, "An Extension of CTN 31GB0607 to Evaluate Long Term Safety of NASHA Treatment in the Breast". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT01609400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*